We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

118 hedge funds and large institutions have $202M invested in PTC Therapeutics in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more call options, than puts

Call options by funds: $4.23M | Put options by funds: $1.99M

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

7% more capital invested

Capital invested by funds: $189M → $202M (+$13M)

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

1% less funds holding

Funds holding: 119 → 118 (-1)

Holders
118
Holders Change
-1
Holders Change %
-0.84%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
44
Reduced
33
Closed
22
Calls
$4.23M
Puts
$1.99M
Net Calls
+$2.24M
Net Calls Change
+$739K

Top Buyers

1
PAMU
Pictet Asset Management (UK)
United Kingdom
+$7.5M
2
CCM
Camber Capital Management
Massachusetts
+$4.45M
3
FCM
Frontier Capital Management
Massachusetts
+$3.42M
4
ACM
Asymmetry Capital Management
California
+$2.25M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.98M

Top Sellers

1
SAM
Sectoral Asset Management
Quebec, Canada
-$14.4M
2
Renaissance Technologies
Renaissance Technologies
New York
-$6.21M
3
Millennium Management
Millennium Management
New York
-$3.68M
4
SIM
Spark Investment Management
New York
-$1.76M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$32.3M -$742K -101,194 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$16.4M +$1.98M +269,642 +13%
PAMU
3
Pictet Asset Management (UK)
United Kingdom
$10.8M +$7.5M +1,023,180 +334%
CCM
4
Camber Capital Management
Massachusetts
$10.5M +$4.45M +606,100 +68%
FCM
5
Frontier Capital Management
Massachusetts
$10.1M +$3.42M +466,608 +48%
TAM
6
Tocqueville Asset Management
New York
$9.83M -$641K -87,355 -6%
BFA
7
BlackRock Fund Advisors
California
$9.12M +$428K +58,309 +5%
BB
8
BB Biotech
Switzerland
$8.3M – – –
Fidelity Investments
9
Fidelity Investments
Massachusetts
$7.98M -$1.65K -225 -0%
BIT
10
BlackRock Institutional Trust
California
$5.71M +$14.6K +1,985 +0.2%
BA
11
BlackRock Advisors
Delaware
$5.21M +$82.7K +11,278 +2%
SAM
12
Sectoral Asset Management
Quebec, Canada
$4.56M -$14.4M -1,966,265 -75%
UBS AM
13
UBS AM
Illinois
$4.32M -$152K -20,769 -3%
State Street
14
State Street
Massachusetts
$4.09M -$501K -68,287 -10%
Bank of America
15
Bank of America
North Carolina
$3.53M +$1.37M +186,125 +59%
Northern Trust
16
Northern Trust
Illinois
$3.21M +$397K +54,073 +13%
Jennison Associates
17
Jennison Associates
New York
$3.13M +$1.32M +179,720 +67%
Ameriprise
18
Ameriprise
Minnesota
$2.8M +$498K +67,925 +21%
Franklin Resources
19
Franklin Resources
California
$2.79M – – –
PA
20
Pinnacle Associates
New York
$2.72M -$165K -22,473 -5%
Adage Capital Partners
21
Adage Capital Partners
Massachusetts
$2.46M +$733K +100,000 +40%
JP Morgan Chase
22
JP Morgan Chase
New York
$2.43M +$1.12M +152,402 +79%
GPCM
23
Granite Point Capital Management
Massachusetts
$2.3M +$2.4M +327,579 New
ACM
24
Asymmetry Capital Management
California
$2.15M +$2.25M +306,650 New
BIM
25
Bogle Investment Management
Massachusetts
$1.81M +$1.89M +257,679 New
1
2 3 4 5

PTCT Hedge Fund Activity: Q2 2016 in Review

118 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q2 2016, worth a combined $202M — up 6.9% from $189M a quarter earlier.

Fund positioning in PTCT was balanced in Q2 2016: 22 funds opened new positions, 22 closed out, 44 added to existing stakes and 33 trimmed.

The largest buyer was Pictet Asset Management (UK), adding an estimated $7.5M. The largest seller was Sectoral Asset Management, cutting an estimated $14.4M.

  • 118 institutional investors held PTC Therapeutics (PTCT) as of Q2 2016, down from 119 in Q1 2016.
  • Funds reported $202M of PTC Therapeutics stock for Q2 2016, up 6.9% quarter-over-quarter.
  • 22 funds opened new PTC Therapeutics positions in Q2 2016 and 22 closed out, a net change of 0 holders.
  • The largest PTC Therapeutics buyer in Q2 2016 was Pictet Asset Management (UK), an estimated $7.5M added.
  • The largest PTC Therapeutics seller in Q2 2016 was Sectoral Asset Management, an estimated $14.4M sold.

Based on aggregated 13F filings for Q2 2016.